Chronic PainTrackingCPCNCT02195752
Lexington Observational Study of Treatment With Compounded Pain Creams
An observational study of Chronic Pain and Acute Pain, run by Lexington Independent Studies, LLC at 2 sites in United States.
Trial summary
A two-year + 3 Mo. observational study to track compliance and outcomes in adult patients prescribed compounded pharmaceutical creams for the treatment of pain. The project is designed to accumulate tracking information from both patients and physicians over the course of therapy as a supplement to the ordinary care… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Chronic Pain, Acute Pain
- What is being tested?
- Compounded Pain Cream
- How many people
- 26 participants
- Where
- 2 sitesUnited States
- Study dates
- Nov 2014to May 2015
- How long will I take part?
- 2 Years
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Males and females at least 18 years of age residing in the United States
Who may be able to join
- be informed of the nature of the study and must give written informed consent
- be able to communicate effectively with study personnel
- be diagnosed with a condition for which the physician has prescribed a compounded pain cream.
Who cannot join
- History of allergy or adverse reaction to pain cream ingredients
- History of psychiatric disorders
Trial locations and contacts
2 sites in 1 country.
United States2 sites
Adolphus Anekwe
Gary, Indiana, 46409
Lido Chen
Laguna Hills, California, 92653
About this study
Official title: Observational Study of Patient and Physician Experiences During Treatment of Pain With Compounded Pharmaceuticals
A two-year + 3 Mo. observational study to track compliance and outcomes in adult patients prescribed compounded pharmaceutical creams for the treatment of pain. The project is designed to accumulate tracking information from both patients and physicians over the course of therapy as a supplement to the ordinary care that the patients will normally receive. We seek to discover aspects of successful and unsuccessful treatment using topical pain creams. This information will be analyzed and reports prepared of observations and emergent findings. These reports will be sent during the study every 1 or 2 months to patients, physicians and pharmacists who are participating in the Study. A final compilation of findings and observations will be circulated to participating patients, physicians and pharmacists.
Read the detailed description
Description Of Data Relevant to Objectives:
The primary objective of this study is to document clinical experience. Specifically, the study will collect:
- The expectations from both patient and physician. These underlie patient willingness to use a topical therapy, and the physician's motivation in prescribing.
- What is prescribed and used. The composition of compounded creams vary. Is there an association between the agents / concentrations and the effects on different types of pain?
- Patterns of use of the creams. Do patients follow the prescription; do they adapt frequency and location of application? Why?
- What happens with use? Do pain scores change? How quickly, and in what ways do pain scores change with different diagnoses? What is the impact on patient lives? Are expectations typically fulfilled and/or are there surprises and emergent findings?
- Observations and structured assessments to tabulate the aspects of successful and unsuccessful treatment using topical pain creams of various compositions and for diverse underlying complaints.
- The level of satisfaction and perceived benefit. If treatment is discontinued, is it because the problem has been resolved? Or is there burden, cost or lack of benefit?
- Separate confidential information from patients and physicians so that the study team can learn how closely the patients' observations match those of the physicians. The level and nature of the correspondence between patient observations and clinician observations (or lack of it) will be shared in reports sent to study participants. Such reports will not disclose the identities of either physicians or patients.
- Comments on reports. An area of interest for the study is to investigate the interest in physicians and patients in the reports to be generated concerning the observations from other patients and other physicians. Will patients be interested in their trajectory of treatment? Will sharing the information impact the perceived value of treatment?
Registry Procedures:
- Data capture is done at visits using structured forms developed in consultation with treating physicians.
- Patient data: Patients enter ratings and information using encoded paper forms that are then sent by mail directly to the Lexington data entry service, or online using a secure login to send forms to the study database. Such direct from patient transfer is intended to reduce bias that would otherwise influence self assessments of treatment benefit because of the desire of the patient to please the treating physician.
- Diagnostic standards: International Statistical Classification of Diseases and Related Health Problems, Ninth Revision (ICD9) or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision ( ICD10) codes for diagnosis of pain conditions to be treated are required.
- Checklists for each visit are completed as part of the trial record to ensure standard processes are followed by treating physicians.
- If missing or illegible data are not resolvable, then there will be NO imputation. Reports and analysis will be based only on entries where source values were clear. Data entry forms include range and completeness checks, prevention of illogical entry. Free text fields are important for capturing unexpected events and observations. These will be recorded verbatim into the database.
- There is no primary hypothesis under test. Observations reported will include counts for instances and trends. Assessments and ratings will be reported as averages and distributions.
- Conditions
- Chronic Pain, Acute Pain
- Being tested
- Compounded Pain Cream
- Keywords
- Compounded pain cream, Ordinary care, Compounding, Topical treatment, Analgesia
- Medical subject headings
- Chronic Pain, Acute Pain, Agnosia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Compounded Pain CreamOther
All patients will have been prescribed a topical pain cream prepared by a qualified compounding pharmacy
| Study group | Role | What they receive |
|---|---|---|
| Prescribed Compounded Pain Cream | The study is limited to patients who have been prescribed treatment with a topical compounded pain cream as a component of their ordinary care by a qualified physician. Receives: Other: Compounded Pain Cream |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in patient reported pain levels following treatment
Across active subjects who have a Baseline pain level AND a followup pain level as of 1 year following first patient enrolled (FPI). Applies to the intended use of the pain cream as established by the diagnosis and area to be treated.
Measured: One year following first patient enrolled
Secondary outcomes (1)
Patient global impression of benefit
Assessed by a structured VAS for completion at followup and final visits. Will be assessed for all patients who have reported on the first followup visit. Mean and distribution will be reported.
Measured: One year after first patient enrolled
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Jul 2014 (estimated)
- Study startNov 2014
- Primary completionApr 2015
- Study completionMay 2015
Why it stopped: Sponsor financial decision stemming from low recruitment
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Chronic PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 26 participants (actual)
- Target duration
- 2 Years
Sponsor and investigators
- Lead sponsor
- Lexington Independent Studies, LLC
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Palm Beach CRO
- Responsible party
- Sponsor
- Investigators
- Stephen A. Raymond, PhD, Study director, Research and Marketing Consultants
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02195752
- Sponsor's protocol ID
- LIS001
- Acronym
- TrackingCPC
- Status last verified
- May 2015
- First submitted
- 15 Jul 2014
- Last updated
- 12 May 2015
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 May 2015. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Observational Study of Patient and Physician Experiences During Treatment of Pain With Compounded Pharmaceuticals
- ClinicalTrials.gov ID
- NCT02195752
- Acronym / sponsor ID
- TrackingCPC / LIS001
- Conditions
- Chronic Pain, Acute Pain
- Keywords
- Compounded pain cream, Ordinary care, Compounding, Topical treatment, Analgesia
- Study type
- Observational
- Recruitment status
- TerminatedReason stopped: Sponsor financial decision stemming from low recruitment
- Enrolment
- 26 participants (actual)
- Lead sponsor
- Lexington Independent Studies, LLCIndustry (pharma, biotech, devices)
- Collaborators
- Palm Beach CRO
- Study start
- Nov 2014
- Primary completion
- Apr 2015 (actual)
- Study completion
- May 2015 (actual)
- First posted
- 21 Jul 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A two-year + 3 Mo. observational study to track compliance and outcomes in adult patients prescribed compounded pharmaceutical creams for the treatment of pain. The project is designed to accumulate tracking information from both patients and physicians over the course of therapy as a supplement to the ordinary care that the patients will normally receive. We seek to discover aspects of successful and unsuccessful treatment using topical pain creams. This information will be analyzed and reports prepared of observations and emergent findings. These reports will be sent during the study every 1 or 2 months to patients, physicians and pharmacists who are participating in the Study. A final compilation of findings and observations will be circulated to participating patients, physicians and pharmacists.
Detailed description
Description Of Data Relevant to Objectives:
The primary objective of this study is to document clinical experience. Specifically, the study will collect:
- The expectations from both patient and physician. These underlie patient willingness to use a topical therapy, and the physician's motivation in prescribing.
- What is prescribed and used. The composition of compounded creams vary. Is there an association between the agents / concentrations and the effects on different types of pain?
- Patterns of use of the creams. Do patients follow the prescription; do they adapt frequency and location of application? Why?
- What happens with use? Do pain scores change? How quickly, and in what ways do pain scores change with different diagnoses? What is the impact on patient lives? Are expectations typically fulfilled and/or are there surprises and emergent findings?
- Observations and structured assessments to tabulate the aspects of successful and unsuccessful treatment using topical pain creams of various compositions and for diverse underlying complaints.
- The level of satisfaction and perceived benefit. If treatment is discontinued, is it because the problem has been resolved? Or is there burden, cost or lack of benefit?
- Separate confidential information from patients and physicians so that the study team can learn how closely the patients' observations match those of the physicians. The level and nature of the correspondence between patient observations and clinician observations (or lack of it) will be shared in reports sent to study participants. Such reports will not disclose the identities of either physicians or patients.
- Comments on reports. An area of interest for the study is to investigate the interest in physicians and patients in the reports to be generated concerning the observations from other patients and other physicians. Will patients be interested in their trajectory of treatment? Will sharing the information impact the perceived value of treatment?
Registry Procedures:
- Data capture is done at visits using structured forms developed in consultation with treating physicians.
- Patient data: Patients enter ratings and information using encoded paper forms that are then sent by mail directly to the Lexington data entry service, or online using a secure login to send forms to the study database. Such direct from patient transfer is intended to reduce bias that would otherwise influence self assessments of treatment benefit because of the desire of the patient to please the treating physician.
- Diagnostic standards: International Statistical Classification of Diseases and Related Health Problems, Ninth Revision (ICD9) or International Statistical Classification of Diseases and Related Health Problems, Tenth Revision ( ICD10) codes for diagnosis of pain conditions to be treated are required.
- Checklists for each visit are completed as part of the trial record to ensure standard processes are followed by treating physicians.
- If missing or illegible data are not resolvable, then there will be NO imputation. Reports and analysis will be based only on entries where source values were clear. Data entry forms include range and completeness checks, prevention of illogical entry. Free text fields are important for capturing unexpected events and observations. These will be recorded verbatim into the database.
- There is no primary hypothesis under test. Observations reported will include counts for instances and trends. Assessments and ratings will be reported as averages and distributions.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Target follow-up
- 2 Years
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Prescribed Compounded Pain Cream | – | Other: Compounded Pain CreamThe study is limited to patients who have been prescribed treatment with a topical compounded pain cream as a component of their ordinary care by a qualified physician. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Males and females at least 18 years of age residing in the United States
Key inclusion criteria (3 listed)
- be informed of the nature of the study and must give written informed consent
- be able to communicate effectively with study personnel
- be diagnosed with a condition for which the physician has prescribed a compounded pain cream.
Key exclusion criteria (2 listed)
- History of allergy or adverse reaction to pain cream ingredients
- History of psychiatric disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Compounded Pain CreamAll patients will have been prescribed a topical pain cream prepared by a qualified compounding pharmacy | Other | Prescribed Compounded Pain Cream |
Primary outcome
Change in patient reported pain levels following treatment
Time frame: One year following first patient enrolled
Across active subjects who have a Baseline pain level AND a followup pain level as of 1 year following first patient enrolled (FPI). Applies to the intended use of the pain cream as established by the diagnosis and area to be treated.
1 secondary outcome
Patient global impression of benefit
Time frame: One year after first patient enrolled
Results and safety
The study was stopped early (reason given: Sponsor financial decision stemming from low recruitment). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 May 2015.
Related trials for Chronic Pain
Recruiting
Empowered Relief® for Cancer Survivors With Chronic Pain
Chronic Pain Due to Cancer, Pain Catastrophizing
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
Not yet recruiting
Effect of Lumbar Stabilization Exercises With and Without YTWL (Scapular Stabilization Exercises) on Reducing Chronic Low Back Pain and Related Disability. A Randomized Clinical Trial,
Chronic Non Specific Mechanical Low Back Pain
Not yet recruiting
Comparing Non-Medicine Strategies for Improving Low Back Pain
Chronic Low-back Pain (cLBP), High-Impact Chronic Pain (HICP)
Not yet recruiting
Effect of Pectoral Nerve Block (PECS) Using Magnesium Sulfate Added to Dexamethasone on Quality of Recovery and Chronic Post-Mastectomy Pain
Breast Cancer, Postoperative Pain
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Stephen A. Raymond, PhD study director
Research and Marketing Consultants
2 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Chronic Pain and Acute Pain, run by Lexington Independent Studies, LLC at 2 sites in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 12 May 2015. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 2 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Sponsor financial decision stemming from low recruitment). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in patient reported pain levels following treatment (time frame: One year following first patient enrolled). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2015.